About us

Created in 2010 with the support of the “Grenoble Alpes Incubation” (“GRAIN”) business incubator, Ecrins Therapeutics is a spin-off from the Grenoble Institute of Neurosciences and Joseph Fourier University.

A prize winner of the 2009 and 2010 National Innovation Contest MENRT/ANVAR “Emergence” and “Création-Développement” Grants, the team of Ecrins Therapeutics pursues the pre-clinical and clinical development of new candidate anti-cancer medicines. The company was founded by Drs. Aurélie Juhem and Andrei Popov, supported by Prof. François Berger of the University Joseph Fourier, and the Grenoble University Hospital. Prior to the creation of start-up, the project was awarded the grant “Proof of concept” by the Lyon Auvergne Rhône-Alpes Cancéropôle (CLARA).